Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy

Shonik Ganjoo1, Nahum Puebla-Osorio1, Selene Nanez1

  • 1Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Frontiers in Immunology
|November 10, 2022
PubMed

Insights

The TGF-β superfamily, including BMPs, activins, and GDFs, impacts cancer progression and treatment resistance. This review explores their roles in immune cell function within the tumor microenvironment.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • The TGF-β superfamily regulates crucial physiological processes like cell signaling and differentiation.
  • While TGF-β is well-studied, other members (BMPs, activins, GDFs) roles in cancer immunology are less understood.
  • TGF-β signaling's impact on cancer immunology and immunotherapy resistance is documented, but knowledge gaps exist for related factors.

Purpose of the Study:

  • To review the influence of BMPs, activins, and GDFs on immune cells.
  • To elucidate the roles of these factors in cancer progression.
  • To explore their involvement in resistance to cancer treatments.

Main Methods:

  • Literature review of scientific articles.
  • Analysis of studies focusing on TGF-β superfamily members beyond TGF-β.
  • Synthesis of findings on immune cell modulation in cancer.

Main Results:

  • BMPs, activins, and GDFs significantly affect immune cell behavior in the tumor microenvironment.
  • These factors play roles in promoting or inhibiting cancer progression.
  • Their influence on immunotherapy resistance mechanisms is increasingly recognized.

Conclusions:

  • Understanding BMPs, activins, and GDFs is critical for advancing cancer immunology and therapy.
  • Targeting these factors may offer novel strategies for overcoming treatment resistance.
  • Further research is warranted to fully elucidate their complex roles in cancer immunity.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
638
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.0K